Insight Molecular Diagnostics Inc. Common Stock

IMDXNASDAQ • USD
1.86 USD
↘ 0.28 (13.10%)AT CLOSE (03:59 PM EST)
1.53
↘ 0.34 (18.01%)
POST MARKET (AS OF 07:55 PM EST)
Post Market
AS OF 07:55 PM EST
1.53
↘ 0.34 (18.01%)
🔴Market: CLOSED

Insight Molecular Diagnostics Inc. Common Stock (IMDX) is currently trading at $1.85. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (231.7%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Nov 16, 2026.

Open?$2.16
High?$2.16
Low?$1.85
Prev. Close?$2.14
Volume?176.5K
Avg. Volume?195.5K
VWAP?$1.99
Rel. Volume?0.90x
Bid / Ask
Bid?$1.50 × 2.0K
Ask?$1.58 × 100
Spread?$0.08
Midpoint?$1.54
Valuation & Ratios
Market Cap?60.9M
Shares Out?32.7M
Float?25.8M
Float %?78.9%
P/E Ratio?N/A
P/B Ratio?-2.86
EPS?-$1.51
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.
Employees
58
Market Cap
70.0M
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Listed
2015-12-30
Address
2 INTERNATIONAL PLAZA DR., SUITE 510
NASHVILLE, TN 37217
Phone: 949-409-7600
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
23
Short Sent.?
44
Piotroski F-Score?0/9Weak
Altman Z-Score?-24.90Distress
Confidence?53%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?3.97%Low
Short Interest?1.0M
Days to Cover?5.1
Free Float25.8M
Avg Daily Volume202.8K
Settlement Date2026-10-30
Financial Health
Current Ratio?2.00Strong
Quick Ratio?1.98Adequate
Cash Ratio?1.73Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
S&P
97
-2.86CHEAP▾
P/S?
Peers
100
S&P
3
36.45HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.1CHEAP▾
EV/Sales?
Peers
100
S&P
3
25.82HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
231.7%STRONG▾
ROA?
S&P
3
-167.6%WEAK▾
Cash Flow & Enterprise
FCF?$-30875000
Enterprise Value?$43.1M
Fundamentals ratios updated end of day